Correlation Between Arbutus Biopharma and IVERIC Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arbutus Biopharma and IVERIC Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arbutus Biopharma and IVERIC Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arbutus Biopharma Corp and IVERIC Bio, you can compare the effects of market volatilities on Arbutus Biopharma and IVERIC Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arbutus Biopharma with a short position of IVERIC Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arbutus Biopharma and IVERIC Bio.

Diversification Opportunities for Arbutus Biopharma and IVERIC Bio

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Arbutus and IVERIC is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Arbutus Biopharma Corp and IVERIC Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IVERIC Bio and Arbutus Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arbutus Biopharma Corp are associated (or correlated) with IVERIC Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IVERIC Bio has no effect on the direction of Arbutus Biopharma i.e., Arbutus Biopharma and IVERIC Bio go up and down completely randomly.

Pair Corralation between Arbutus Biopharma and IVERIC Bio

Given the investment horizon of 90 days Arbutus Biopharma is expected to generate 7.36 times less return on investment than IVERIC Bio. But when comparing it to its historical volatility, Arbutus Biopharma Corp is 1.34 times less risky than IVERIC Bio. It trades about 0.03 of its potential returns per unit of risk. IVERIC Bio is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  1,897  in IVERIC Bio on August 31, 2024 and sell it today you would earn a total of  2,098  from holding IVERIC Bio or generate 110.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy26.62%
ValuesDaily Returns

Arbutus Biopharma Corp  vs.  IVERIC Bio

 Performance 
       Timeline  
Arbutus Biopharma Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arbutus Biopharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
IVERIC Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days IVERIC Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, IVERIC Bio is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Arbutus Biopharma and IVERIC Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arbutus Biopharma and IVERIC Bio

The main advantage of trading using opposite Arbutus Biopharma and IVERIC Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arbutus Biopharma position performs unexpectedly, IVERIC Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IVERIC Bio will offset losses from the drop in IVERIC Bio's long position.
The idea behind Arbutus Biopharma Corp and IVERIC Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope